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Abstract: 
Pheretima (family Megascolecidae) has been documented as a potent agent for the treatment of 
cough and breathing difficulty in traditional Chinese medicine for nearly 2000 years. The water 
extract of Pheretima was separated into three fractions of the ethanolic precipitate, the alkaline 
fraction and the acidic fraction. Among the three fractions, the acidic fraction showed the most 
potent spasmolytic effects on histamine-induced contractions in isolated guinea pig tracheal 
rings, and the most inhibitory activities on increase of short circuit current induced by carbachol 
in isolated rat tracheal epitheliums with the IC50 values of 0.15 and 0.08 mg/ml, respectively. 
Further in vivo studies also displayed that the acidic fraction could protect experimental asthma 
model induced by the combination of histamine and acetylcholine chloride in guinea pigs to 
prolong the latent periods of asthma (P < 0.05) and significantly decrease the cough frequency 
caused by ammonia water in mice (P < 0.001). 
 
Article: 
INTRODUCTION 
Asthma is a chronic inflammatory disease of the respiratory tract that is characterized by 
increased airway hyper-responsiveness and mucus production that leads to episodes of wheezing, 
coughing and shortness of breath. Asthma is common among the individuals (up to 10% in adults 
and 35% in children), and as a result, large quantities of asthma medications are needed to stop 
the asthma prevalence increase (Annesi-Maesano, 2005). Because of little adverse effect 
compared to those of steroids or other synthetic drugs to prevent and treat such repetitious 
chronic disease, there are increasing demands for the use of traditional natural drugs in the 
therapy of asthma. In traditional Chinese medicine (TCM), Pheretima (family Megascolecidae) 
has been documented as an anti-asthmatic remedy in the earliest material medica “Shennong 
Bencao Jing” (Donghan dynasty, about 1900 years ago). It has been acclaimed that Pheretima is 
a potent agent for the treatment of cough and breathing difficulty owing to various exogenous or 
interior heat reasons in the folk medicine. Four different kinds of earthworms, Pheretima 
aspergillum (E. Perrier), Pheretima guillelmi (Michaelsen), Pheretima vulgaris Chen and 
Pheretima pectinifera Michaelsen are collected in the Pharmacopoeia of People's Republic of 
China (2005, edition I) for anti-asthmatic remedies and all named as Pheretima. Among the four 
kinds, the first one is conventionally called as Guang-Pheretima (mainly collected from Guang-
dong province, China) while the rest of ones are called as Hu Pheretima (collected from 
Shanghai area). 
 
Dried powder and hot water extract of Pheretima are the two main pharmaceutical forms to 
manage asthma in TCM (Li et al., 1997), however, the active components and the 
pharmacological mechanisms have not been thoroughly investigated so far due to its complexity 
of the ingredients. The present study was undertaken to separate Pheretima into three parts of 
extracts, and to screen the active parts of Pheretima with spasmolytic effects on the carbachol 
and histamine contracted guinea-pig tracheal smooth muscles in vitro and with mucus secretion 
inhibitory effects on carbachol-evoked isolated rat tracheal epitheliums in vitro. Additionally, the 
protective effect of the acidic fraction on broncho-constriction and the antitussive effect were 
evaluated in vivo. 
 
MATERIALS AND METHODS 
Collection and preparation of material 
The materials were purchased from Huayu Pharmaceutical Company in Shanghai. The 
authenticated samples were identified as Pheretima vulgaris Chen by Dr. Zhong Liu, Associate 
Professor in Pharmacognosy at School of Pharmacy, Shanghai Jiao Tong University (SJTU) and 
the voucher specimen (SJTU 05-12-01) were deposited in the Herbarium of School of Pharmacy, 
SJTU. The dried earthworms were previously eviscerated with the viscera and organic 
components washed away by the supplier, and reduced to coarse powder in our laboratory for 
experimental use. Other chemicals reagents were obtained from Sigma Chemical Co. The test 
samples were dissolved in distilled water, and distilled water served as negative control. All 
animal experiments were conducted in accordance with the internationally accepted principles 
for laboratory animal use and care in the European Community guidelines (EEC Directive of 
1986; 86/609/EEC) and all efforts were made to minimize animal suffering. 
 
Extraction and separation of three fractions from Pheretima 
Each of the extractive fractions of Pheretima was obtained according to the procedure described 
in Fig. 1. The yields were expressed as the weight of prepared extracts in the total weight of 
starting crude material, specifically, 6.13% ethanolic precipitate, 7.25% alkaline fraction and 
13.23% acidic fraction respectively. 
 
Figure 1: Procedures for isolation of ethanolic precipitate fraction, acidic faction and alkaline fraction from dried 
Pheretima powder. 
 
 
Analysis of three fractions from Pheretima 
Analysis of the acidic fraction with pH 4 of Pheretima was performed using combined gas 
chromatography and mass spectrometry (GC–MS) method with ethyl chloroformate (ECF) 
derivatization agents (Qiu et al., 2007) which revealed that the extract consists of amino acids 
and fatty acids. Chemical analyses indicated that alkaline fraction with PH11 contains mainly 
guanidines, and the ethanolic precipitate fraction contains mainly proteins. 
 
Protocols 
Spasmolytic tests of three fractions in vitro. Guinea pigs of male sex (200–250 g) starved 
overnight, but free access to water, were used. The animals were sacrificed by intraperitoneal 
injection of sodium pentobarbital, and the section of trachea between the larynx and sternum was 
removed and dissected into 6–8 small rings. The small rings were then suspended in a 8 ml organ 
bath containing K–H (Krebs–Henseleit) solution of the following composition (mM): NaCl 
118.4, KCl 4.7, KH2PO4 1.2, NaHCO3 25.0, CaCl2 2.5, MgSO4 1.2, glucose 11.1, pH 
7.4 ± 0.05. The K–H solution was maintained at 37 °C and gassed with 95% O2 and 5% CO2. 
Tissue was suspended under isotonic tension of 1.5 g and allowed to equilibrate for at least 1h 
before experiment during which the solution was replaced for once a time. Maximum contraction 
was elicited by carbachol (10 μM) or histamine (10 μM) in each tracheal ring at the beginning of 
the experiment. The responses of the extracts (up to 2.03 mg/ml) on elicited contraction were 
recorded after exposing tissue to the dose-accumulating solution for 5 min. The spasmolytic 
effects were examined by producing cumulative log concentration–response curve. A decrease in 
tone was considered as relaxant effect (Fig. 2). The relaxant responses were expressed as 
percentages of inhibition on maximal contraction produced by the agonists. Responses were 
recorded on ML740 (Power Lab data acquisition systems) with Chart V 3.4.6 recorder and 
analysis software (Shibata et al., 1998). 
 
 
 
Figure 2: Representative of tracings of tension in isolated guinea pig tracheal rings evoked by 10 μM histamine 
resulting in a significant increase in tension. After the increased tension was sustained at relatively stable levels, the 
acidic fraction solution with increasing concentrations was added, leading to a decrease tone in dose-dependent 
manner. The down arrows showed cumulative concentration of the extract in the organ bath. 
 
 
Transepithelial ion transport tests of three fractions in vitro. Male Sprague Dawley rats 
(200–250 g) were sacrificed by intraperitoneal injection of sodium pentobarbital. The distal two-
thirds of the tracheas were separated, longitudinally opened on the ventral side and mounted in 
modified Ussing chambers. The lucite chambers exposed 0.1 cm2 tracheal surfaces to separate 
reservoirs (5 ml) containing gassed (95% O2, 5% CO2) K–H solution (in mM: NaCl 115, 
K2HPO4 2.2, KH2PO4 0.4, NaHCO3 25, CaCl2 1.2, MgCl2 1.2, glucose 5.1, pH 7.4 ± 0.05) at 
37 °C. Constant potential pulses (mV) were passed through the samples using a pulse generator. 
The transepithelial short circuit current (Isc) and potential were measured using CEZ-9100 
amplifiers (Physiologic Instruments, San Diego, CA) and a voltage current clamp (VCC MC-2, 
Physiologic Instruments, San Diego, CA) connected to the mucosal and submucosal solutions by 
calomel half cells and 3 M KCl–4% agar bridges, with tips closely opposed to the tissue sample 
(Roche et al., 2000). The transepithelial resistance (Rte) was calculated according to Ohm law 
(Rte = ΔVte/I). After the establishment of a steady state, as indicated by maintenance of stable 
basal Isc readings, 10 μM carbachol was added to evoke a sharp increase in Isc. When the 
increases in Isc were sustained at relatively stable levels for at least 10 min, one of the test 
extracts (ethanolic precipitate, alkaline or acidic faction) with increasing concentration was 
added to the mucosal reservoir at 10 min intervals (final concentration up to 2.00 mg/ml) (Fig. 
3). Tested extracts remained fully soluble in the bathing solution for the duration of the 
experiment. Tissues with abnormal baseline values of Isc or conductance were considered as 
damaged and excluded. Curves of cumulative concentration–response relationships were 
generated by measuring the peak to baseline increases in Isc induced after each concentration of 
test extract was added cumulatively to the serosal bath. 
 
Figure 3: Representative of tracings of Isc through isolated rat tracheal epithelium challenged with 10 μM carbachol 
resulting in a significant increase in Isc. After the increases in Isc were sustained at relatively stable levels, the acidic 
fraction solution with increasing concentrations was added to the mucosal reservoir, leading to a decrease tone in 
dose-dependent manner. The down arrows showed cumulative concentration of the extract in the mucosal reservoir. 
 
 
The bronchoprotective tests of acidic fraction in vivo. To screen the sensitivity of guinea pigs, 
guinea pigs of both sex (150–200 g) were placed in a plexiglass chamber and sprayed with 0.1% 
histamine and 2% acetylcholine chloride mixed with the same volume under the average 
pressure of 450 ± 50 mmHg for 15 s. The time to onset of respiratory distress (preconvulsive 
time) during challenge with these agents was measured, the guinea pigs with preconvulsive time 
of more than 120 s were considered to be insensitive and discarded. The eligible guinea pigs 
were randomly allotted to different groups with 10 per each. The negative control of animals 
received distilled water orally, and the positive control animals received aminophylline by 
gastric perfusion, the other two groups were treated with acidic fractions of low and high doses 
respectively. All groups were treated with a single dose daily for 3 days prior to the challenge, 
the last dose given 1 h before the challenge. The methods of challenge were the same as those of 
screening the sensitive guinea pigs. The delitescence of convulsion for each guinea pig and 
tumble numbers for each group during challenge within a 6 min exposure period were recorded. 
Protection from convulsion was expressed relative to control (Okpo and Adeyemi, 2002). 
 
Antitussive tests of the acidic fraction in vivo. ICR mice of both sex weighing about 20 g were 
divided into four groups, 10 mice per group. The negative control of animals received distilled 
water orally, and the positive control received pentoxyverine, the remaining groups received low 
and high doses of acidic fraction by gastric perfusion respectively. The in vivo antitussive 
activity was investigated on a classical mouse cough model induced by ammonia liquor (Xu et 
al., 1991). Briefly, mice were placed in a special glass chamber and exposed for 5 s to a 28% 
NH4OH aerosol which was produced through a nebulizer by compressed air at a pressure of 
about 400 mmHg. The cough frequency produced during a 3-min exposure period was counted. 
The cough frequency for the test groups (Ct) was compared with those of control group (Cc), the 
antitussive effect was expressed as below: % inhibition = (Cc − Ct)/Cc × 100. 
 
 
 
Statistical analysis 
Data from experiments was analyzed and expressed as mean ± S.E.M., paired t-tests and the 
software of origin 7.0 were employed. 
 
RESULTS 
Spasmolytic effect of three fractions in vitro 
On carbachol-contracted isolated guinea pig tracheal rings, the maximal bronchodilatory effects 
of all three fractions were statistically significant as compared to those of control (Table 1), 
indicating that all three extracts had bronchodilatory effects on carbachol-induced contraction 
dose-dependently (Fig. 4). The order of bronchodilatory effect was acidic fraction > alkaline 
fraction > ethanolic precipitate (Table 1). 
 
Table 1: Comparison of maximal relaxations of the extracts on isolated guinea pig tracheal rings 
contractions induced by two different agonists (n = 6) 
Group Carbachol  Histamine 
 Dose (mg/ml) Relaxation (%)  Dose (mg/ml) Relaxation (%) 
Control – 8.29 ± 0.34  – 12.08 ± 3.13 
Acidic fraction 1.35 35.53 ± 4.07**  1.35 78.28 ± 3.75** 
Alkaline fraction 1.05 27.47 ± 3.01**  0.53 26.47 ± 8.87▵▵ 
Ethanolic precipitate 1.35 24.58 ±7.75*  0.45 41.74 ± 12.01*▵ 
Values are presented as mean ± S.E.M. *P < 0.05 and **P < 0.01 statistical significance vs. control; ▵P < 0.05 and ▵▵P < 0.01 statistical 
significance vs. the acidic fraction. 
 
 
 
Figure 4: Effects of cumulative addition of extracts on carbachol-induced contraction in guinea pig tracheal rings. 
 
 
On histamine-contracted isolated guinea pig tracheal rings, the maximal bronchodilatory effects 
of the acidic fraction and ethanolic precipitate were statistically significant as compared to those 
of control (Table 1), suggesting that the two fractions had relaxant effects on histamine-
contracted tracheal smooth muscles. Additionally, the inhibitory effect of the acidic faction on 
histamine-induced contraction with IC50 (the concentration causing 50% inhibitory effect) being 
0.15 mg/ml was much more potent than that of the ethanolic precipitate fraction (Table 1) 
without producing 50% inhibitory response (Fig. 5). On the other hand, the effect of the alkaline 
fraction was not statistically significant as compared to that of negative control (Table 1), 
suggesting that the alkaline fraction might have little or no bronchodilatory effect on histamine-
evoked contraction. 
 
 
Figure 5: Effects of cumulative addition of extracts on histamine-induced contraction in guinea pig tracheal rings. 
 
 
The above results suggested that the acidic faction was the most effective fraction with 
spasomatic activity on isolated guinea pig tracheal rings in dose-dependent manner, and the 
maximal relaxant effect of 78.00% on histamine-induced contraction is greater than that 
(35.53%) on carbachol-induced contraction. 
 
Inhibitory effects on carbachol-induced Isc in vitro 
Baseline values for Isc, Vt and Rt in intact rat tracheas (n = 7) were 34.4 ± 6.0 μA/cm2, 
−5.3 ± 0.6 mV, 106.8 ± 12.0 Ω cm2 respectively. The 10 μM carbachol evoked a rapid Isc 
increase response within 2 min. The maximal reduction in carbachol-induced Isc by the acidic 
fraction were significantly different from that of control (Table 2, Fig. 6), indicating that this 
fraction had inhibitory effect on Isc increase evoked by carbachol, in a dose-dependent manner 
(Fig. 3) with IC50 0.08 mg/ml. The maximal reduction in carbachol-induced Isc by the alkaline 
and ethanolic precipitate fraction were not statistically significant compared with control (Table 
2, Fig. 6), suggesting that the alkaline fraction and ethanolic precipitate had little or no effect on 
ion transport evoked by carbachol. 
 
Table 2: Comparison of maximal inhibition of extracts with corresponding doses on carbachol-
induced Isc increases through isolated rat tracheal epitheliums (n = 6) 
Group Dose (mg/ml) Inhibition (%) 
Control – 20.72 ± 6.33 
Acidic fraction 0.68 83.76 ± 6.52** 
Alkaline fraction 0.53 34.60 ± 9.54▵▵▵ 
Ethanolic precipitate 0.45 20.73 ± 4.34▵▵ 
Values are presented as mean ± S.E.M. **P < 0.01 statistical significance vs. control; ▵▵P < 0.01 and ▵▵▵P < 0.001 statistical significance vs. the 
acidic fraction. 
 
Figure 6: Effects of cumulative addition of extracts on carbachol-induced increase in Isc through 
isolated rat tracheal epitheliums. 
 
Spasmolytic effects of the acidic fraction in vivo 
The effects of the acidic fraction on sensitive guinea pigs exposed to mixture spray of 0.1% 
histamine and 2% acetylcholine chloride were shown in Table 3. A high dose (504 mg/kg) of this 
fraction produced good prolongation effects of preconvulsive time (P < 0.001), not significantly 
different from that of the positive control, aminophylline. On the other hand, in this dose, this 
fraction decreased the tumble numbers of guinea pigs compared to vehicle, which also showed a 
bronchoprotective effects on mixture of histamine and acetylcholine chloride induced 
bronchoconstriction. However, at the low dose (252 mg/kg), this fraction did not exhibit 
significant bronchoprotective effect. 
 
Table 3: Effect of acidic fraction on guinea pigs bronchoconstriction induced by mixture spray 
of histamine and acetylcholine chloride (n = 10) 
Group Dose (mg/kg) Tumble numbers Preconvulsive time (min) 
Negative control – 10 45.57 ± 3.48 
Aminophylline 171 6 78.00 ± 3.89*** 
Acidic fraction 252 9 54.17 ± 4.67▵▵ 
 504 5 79.86 ± 11.71* 
Values are presented as mean ± S.E.M. *P < 0.05 and ***P < 0.001 statistical significance vs. negative control; ▵▵P < 0.01 statistical 
significance vs. positive control. 
 
Antitussive effects of the acidic fraction in vivo 
The cough frequency obtained in the presence of low dose (252 mg/kg) and high dose 
(504 mg/kg) of acidic fraction of Pheretima extract compared to those obtained in the presence 
of vehicle and positive control were shown in Table 4, both groups showed significant 
antitussive activities (P < 0.01 and P < 0.001) which were comparable with that of positive 
control, pentoxyverine. 
 
 
Table 4: Effect of acidic fraction on cough mice induced by ammonia (n = 10) 
Group Dose (mg/kg) Cough frequency within 3 min Inhibition (%) 
Negative control – 66.40 ± 3.08 – 
Pentoxyverine 33.33 45.78 ± 3.45** 31.05 
Acidic fraction 252 45.60 ± 3.91** 31.33 
 504 45.17 ±3.30*** 31.97 
Values are presented as mean ± S.E.M. **P < 0.01 and ***P < 0.001 statistical significance vs. negative control. 
 
DISCUSSION 
In the present study, the water extract from Pheretima was separated into three fractions of the 
ethanolic precipitate, the alkaline fraction and the acidic fraction over anion resin 
chromatography. Through the pharmacological evaluation of relaxant effects on contraction 
induced by histamine and carbachol on isolated guinea pig tracheal rings as well as the inhibitory 
effects on carbachol-induced Isc increase in isolated rat tracheal epitheliums, the acidic fraction 
appeared to be the most active part in asthma-relieving in vitro. Results from in vivo evaluation 
with the acidic fraction on the bronchoconstriction induced by mixed spray of histamine and 
acetylcholine chloride in guinea pigs, strongly supported the in vitro observation of the 
bronchodilatory effect of this fraction. Additionally, this acidic fraction also showed significant 
antitussive effects on cough model induced by ammonia water in mice in vivo. All these results 
persuaded us to draw a conclusion that the acidic fraction played an important role in asthma-
relieving among the three water extractive fractions from Pheretima. 
 
The measurement of Isc has widely been used to estimate the ion transportation through 
epithelium, since the ion transport forms local osmotic gradients across epithelia which regulate 
transepithelial water movement (Davis and Nadel, 1980), consequently regulate airway surface 
liquid (ASL) volume (mucus) (Tarran et al., 2001). Furthermore, the ionic composition of the 
tracheal fluid can be manipulated by cholinergic stimulation (Vanthanouvong et al., 2005). 
Therefore the inhibitory activity of the acidic fraction of Pheretima on the increase of Isc induced 
by carbachol in rat tracheal epithelium suggested that this fraction might be effective in 
inhibiting excess mucus (sputum) secretion to relieve airway obstruction owing to mucus hyper-
responsiveness. 
 
GC–MS analyse indicated that the acidic fraction consists of a number of amino acids and fatty 
acids, which may be beneficial for the altered regulatory network and certain ion transportation 
pathways. However, due to the nature of multiple chemical components involved in the drug 
intervention as well as the multi-factorial condition of asthma, it is difficult to ascertain the 
mechanism of action with regard to the inhibition of spasmogen activity, regulation of specific 
ion channel in tracheal epithelium and antitussive effect involved in asthma. 
 
CONCLUSION 
In summary, the anti-asthmatic fraction from the water extract of Pheretima was successfully 
obtained through a series of pharmacological evaluation in vitro and in vivo on the basis of 
traditional use of the Pheretima extraction as anti-asthmatic agent. The acidic fraction of the 
Pheretima inhibited increase of carbachol-induced Isc in vitro, showed significant 
bronchodilatory effect both in vitro and in vivo, and exhibited significant antitussive effects in 
vivo. The bioactive components as well as the mechanisms of action responsible for the observed 
activities have not been established, and thus warrant further investigation. 
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